Back to search

Article

Effect of Dapagliflozin on COVID-19 Infection and Risk of Hospitalization

2023-03-11

Abstract excerpt

Background and Aim: It has been suggested that dapagliflozin might mitigate cytokine production and inflammatory response, which could be of value in patients affected by COVID 19. Due to the paucity of data we aim to assess – by means of several objectives- the effect of dapagliflozin on 1) COVID19 severity: 1.1) risk of hospitalization 1.2) risk of intensive care unit (ICU) admission 1.3) In-hospital death 1.4)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e599a2e8-c983-5330-a094-0ea18edf09d7
DOI
10.2139/ssrn.4383079
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of Dapagliflozin on COVID-19 Infection and Risk of HospitalizationDOI 10.2139/ssrn.4383079
Select a neighboring publication to make it the new centre.